Survey for Participants Currently on PrEP

Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States CHANGE REQUEST to Mitigate COVID-19 Risks: Using Qualitative Methods [...]

Att 2e_Survey on PrEP

Qualitative Research to Understand Consumer Opinions and Preferences for Emerging HIV Prevention Products among MSM in Atlanta, Houston, and Miami

OMB: 0920-1091

Document [docx]
Download: docx | pdf






Qualitative research to understand consumer opinions and preferences for emerging

HIV prevention products among MSM in Atlanta, Houston, and Miami


Attachment 2e: Survey on PrEP



Emerging Prevention Products for MSM

Survey for Participants Currently on PrEP



Shape2

Form Approved

OMB No: 0920-1091

Exp. Date: 09/30/2021


Privacy Act Statement:

This information is collected under the authority of the Public Health Service Act, Section 301, "Research and Investigation," (42 U.S.C. 241); which discuss authority to maintain data and provide privacy for health research and related activities (42 U.S.C. 242 b, k, and m(d)). This information is also being collected in conjunction with the provisions of the Government Paperwork Elimination Act and the Paperwork Reduction Act (PRA). This information will only be used by the Centers for Disease Control and Prevention (CDC) staff to advance understanding of consumer preferences about emerging biomedical products designed to prevent HIV transmission among men who have sex with men.


Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333. Attn: OMB-PRA (0920-1091)



Respondent ID:_______________


Thank you for agreeing to participate in this survey. Your input is very important to us.


STUDY ID NUMBER: _____________


Section 1: Questions about You

D1. How old are you?


_________ years


D2. Which of the following best describe your ethnicity?

Shape3

1 Hispanic or Latino

Shape4

0 Not Hispanic or Latino


D3. Which race or races, do you consider yourself to be?

Select all that apply

Shape5

1 American Indian or Alaska Native

2 Asian

3 Black or African American

4 Native Hawaiian or Other Pacific Islander

5 White




D4. What is your country of birth?


Shape6
  1. United States

  2. Other Specify:_________________



D5. What is the highest level of education that you have completed?

Shape7

1 Less than high school

Shape8

2 High school diploma or GED

Shape9

3 Some College, Associate’s Degree, or Technical Degree

Shape10

4 Bachelor’s/4-year College Degree

Shape11

5 Any post-graduate degree


D6. Which of the following best represents how you think of yourself?

Shape12

1 Lesbian or gay

Shape13

2 Straight, that is not lesbian or gay

Shape14

3 Bisexual

Shape15

4 Something else

Shape16

7 I don’t know the answer


D7. Do you currently have health insurance or health care coverage (including Medicare or Medicaid)?

Shape17

1 Yes

Shape18

0 No

Shape19

7 I don’t know

9 I prefer not to answer



Section 4: Questions about PrEP

P1. In the past 7 days, on how many days did you take your dose of PrEP?


_______ days



P2. If you missed any PrEP doses in the past 7 days, why did you miss your PrEP dose?

Select all that apply

Shape20

I forgot

I was busy

I didn’t want to take it

My prescription ran out

I didn’t miss any doses

Shape21

Other. Specify:_________________







P3. Where have you heard about PrEP the most?

Select one response

Shape22

Sex partners

Friends or family

Health providers or counselors

Sex or dating websites

Other social media (e.g. Facebook, Instagram, Snapchat).

News media

Advertisements around town

Other. Specify: __________________________________



P4. Have you ever stopped taking PrEP on purpose?

Shape23
  1. No (GO TO P6)

1 Yes (GO TO P5)







P5. What was the most important reason you stopped taking PrEP?

Select one response

Shape24

My insurance wouldn’t cover it

I couldn’t afford it

I decided I didn’t need it for protection anymore

My relationship status changed

I don’t think it worked very well to protect me

I didn’t like the side effects

I was worried about the safety of PrEP

It was too hard taking the pills

My doctor decided to take me off it

I don’t have anybody to prescribe it to me

Other. Specify: __________________________________












P6. Which one of the following statements best reflects your thoughts about taking PrEP in the future.

Select one response

Shape25

I am planning to continue to use PrEP (END OF SURVEY)

I plan to stop PrEP in the coming weeks (GO TO P7)

Shape26

I plan to stop taking PrEP in the next 1-5 months (GO TO P7)

Shape27

I plan to stop taking PrEP in the next 6-12 months (GO TO P7)

Shape28

I am not sure


P7. If you plan to stop taking PrEP, what is the most important reason for stopping?

Select one response

Shape29

My insurance doesn’t cover it

I can’t afford it

I don’t think I need it for protection anymore

My relationship status has changed

I don’t think it works very well to protect me

I don’t like the side effects

I am worried about the safety of PrEP

It is too hard taking the pills

My doctor plans to take me off it

I don’t have anybody to prescribe it to me

Other. Specify: __________________________________




Thank you for your valuable input on this survey!



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorGordon Mansergh
File Modified0000-00-00
File Created2021-01-13

© 2024 OMB.report | Privacy Policy